Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Sheep toxin could be linked to MS
“There is a growing body of wider evidence that points to a hypothesis linking MS and ETX".

Discovery could lead to new tests and treatments 

Scientists say exposure to a toxin found in sheep could be linked to the development of multiple sclerosis (MS) in humans.

A study by the University of Exeter and MS Sciences Ltd found that people with MS are more likely to have antibodies against the epsilon toxin (ETX), which suggests they have been exposed to it at some point.

ETX is produced in the gut of livestock by the bacterium, Clostridium perfringens. Whilst it can occur in other animals and even soil, it has primarily been studied as a cause of enterotoxaemia in sheep.

Researchers found 43 per cent of patients with MS were positive for antibodies to ETX, compared to 16 per cent of healthy participants.

Simon Slater, director of MS Sciences Ltd, said: “There is a growing body of wider evidence that points to a hypothesis linking MS and ETX, and we are confident that these significant findings from our latest study will help people get even closer to an answer for the elusive triggers of MS”.

If the link is proven, it would suggest that a vaccine could prevent MS in the early stages of the disease, Slater added.

However, the causes of the disease are not yet fully understood and further research is needed to understand how ETX may be involved in MS and how such findings could be used to develop tests or treatments.

MS is most commonly diagnosed in patients in their 20s and 30s and can affect the brain, causing a wide range of symptoms including problems with vision, movement, sensation and balance. It is estimated that more than a 100,000 people in the UK are diagnosed with MS.

The full research paper is published in the Multiple Sclerosis Journal: Click here

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.